Translational AI and Deep Learning in Diagnostic Pathology

被引:156
作者
Serag, Ahmed [1 ]
Ion-Margineanu, Adrian [1 ]
Qureshi, Hammad [1 ]
McMillan, Ryan [1 ]
Saint Martin, Marie-Judith [1 ]
Diamond, Jim [1 ]
O'Reilly, Paul [1 ]
Hamilton, Peter [1 ]
机构
[1] Philips, Digital & Computat Pathol, Life Sci R&D Hub, Belfast, Antrim, North Ireland
关键词
pathology; digital pathology; artificial intelligence; computational pathology; image analysis; neural network; deep learning; machine learning; LOCALIZED PROSTATE-CANCER; BREAST-CANCER; ARTIFICIAL-INTELLIGENCE; NEURAL-NETWORKS; CELL DETECTION; IMAGE-ANALYSIS; SEGMENTATION; KI-67; CLASSIFICATION; PERCENTAGE;
D O I
10.3389/fmed.2019.00185
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There has been an exponential growth in the application of AI in health and in pathology. This is resulting in the innovation of deep learning technologies that are specifically aimed at cellular imaging and practical applications that could transform diagnostic pathology. This paper reviews the different approaches to deep learning in pathology, the public grand challenges that have driven this innovation and a range of emerging applications in pathology. The translation of AI into clinical practice will require applications to be embedded seamlessly within digital pathology workflows, driving an integrated approach to diagnostics and providing pathologists with new tools that accelerate workflow and improve diagnostic consistency and reduce errors. The clearance of digital pathology for primary diagnosis in the US by some manufacturers provides the platform on which to deliver practical AI. AI and computational pathology will continue to mature as researchers, clinicians, industry, regulatory organizations and patient advocacy groups work together to innovate and deliver new technologies to health care providers: technologies which are better, faster, cheaper, more precise, and safe.
引用
收藏
页数:15
相关论文
共 116 条
[1]   Prognostic value of automated KI67 scoring in breast cancer: a centralised evaluation of 8088 patients from 10 study groups [J].
Abubakar, Mustapha ;
Orr, Nick ;
Daley, Frances ;
Coulson, Penny ;
Ali, H. Raza ;
Blows, Fiona ;
Benitez, Javier ;
Milne, Roger ;
Brenner, Herman ;
Stegmaier, Christa ;
Mannermaa, Arto ;
Chang-Claude, Jenny ;
Rudolph, Anja ;
Sinn, Peter ;
Couch, Fergus J. ;
Devilee, Peter ;
Tollenaar, Rob A. E. M. ;
Seynaeve, Caroline ;
Figueroa, Jonine ;
Sherman, Mark E. ;
Lissowska, Jolanta ;
Hewitt, Stephen ;
Eccles, Diana ;
Hooning, Maartje J. ;
Hollestelle, Antoinette ;
Martens, John W. M. ;
van Deurzen, Carolien H. M. ;
Bolla, Manjeet K. ;
Wang, Qin ;
Jones, Michael ;
Schoemaker, Minouk ;
Wesseling, Jelle ;
van Leeuwen, Flora E. ;
Van 't Veer, Laura ;
Easton, Douglas ;
Swerdlow, Anthony J. ;
Dowsett, Mitch ;
Pharoah, Paul D. ;
Schmidt, Marjanka K. ;
Garcia-Closas, Montserrat .
BREAST CANCER RESEARCH, 2016, 18
[2]  
Agrawal P., 2018, Journal of Pharmacovigilance, V6, DOI DOI 10.4172/2329-6887.1000E173
[3]   Automating Proliferation Rate Estimation from Breast Cancer Ki-67 Histology Images [J].
Al-Lahham, Heba Z. ;
Alomaria, Raja S. ;
Hiary, Hazem ;
Chaudhary, Vipin .
MEDICAL IMAGING 2012: COMPUTER-AIDED DIAGNOSIS, 2012, 8315
[4]  
[Anonymous], 2017, INFORM PROCESSING ME
[5]  
[Anonymous], 2019, PREDICTIVE BIOMARKER
[6]  
[Anonymous], P SPIE
[7]  
[Anonymous], 2016, TEST TIM COM EV PATH
[8]  
[Anonymous], 2018, ARXIV PREPRINT ARXIV
[9]  
[Anonymous], 2014, 22 INT C PATT REC IC
[10]  
[Anonymous], MOBIHEALTHNEWS